Skip to main content
Pumps

TECHNOLOGY THAT TRANSFORMS LIVES

Discover our insulin pump therapies and guide your patients to find the right solution to live life on their terms

SmartGuard™ technology helps prevent highs & Lows
3.95.510(mmol/L)16:0020:00Helps prevent highs1,2Gives you more insulin if you’re trending high*Auto corrects highs early, before they occur1,2Adjusted small auto correction dosing, up to every 5 minutes*Helps prevent lows1,2Gives you less insulin if you’re trending low*Glucose LevelsBasal InsulinAuto correction bolus 3.9 5.5 10(mmol/L)16:0020:00Helps prevent highs1,2Gives you more insulin if you’re trending high*Auto corrects highs early, before they occur1,2Adjusted small auto correction dosing, up to every 5 minutes*Helps prevent lows1,2Gives you less insulin if you’re trending low*Glucose LevelsBasal InsulinAuto correction bolus SmartGuard™ technology helps prevent highs & Lows 1,2

For illustrative puposes only.

* Refers to System User Guide - SmartGuard™ feature. Some interaction required.

740G

MiniMed™ 740G system with SmarGuard™ Technology

Predicts and prevents lows before your patients ever feel them.

  • Provides advanced protection from hypoglycaemia, compared to CSII Therapy
  • 73% less hypoglycaemia
  • 79% less time spent in hypoglycaemias
  • 84% less severe hypoglycaemias

*MiniMed™ 740G and the MiniMed™ 640G system share the same therapy algorithm.

DOWNLOAD BROCHURE

  1. Carlson AL, et al. Poster # 97 at the 80th International Conference of the American Diabetes Association, June 2020, Chicago/Virtual.
  2. Medtronic data on file: Pivotal Trial (Age 14-75). N=157. 16 US sites; 2020.
  3. Battelino T, et al. Diabetes Care 2019; 42(8): 1593-1603.
  4. ADA Guidelines of A1C<7.0 – www.Diabetes.org
  5. Bosi E, et al. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemiaprone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial. Lancet Diabetes Endocrinol 2019;7: 462–72.
  6. Berganstal RM, et al. Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes. N Engl J Med 2010; 363:311-320